ENTRY       D10398                      Drug
NAME        Radium Ra 223 dichloride (USAN);
            Xofigo (TN)
PRODUCT     XOFIGO (Bayer HealthCare Pharmaceuticals)
FORMULA     RaCl2
EXACT_MASS  292.9562
MOL_WEIGHT  296.906
REMARK      Therapeutic category: 4291
            ATC code: V10XX03
            Product: D10398<JP/US>
EFFICACY    Antineoplastic, Radioactive agent
  DISEASE   Prostate cancer, castration-resistant [DS:H00024]
TARGET      DNA
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             V VARIOUS
              V10 THERAPEUTIC RADIOPHARMACEUTICALS
               V10X OTHER THERAPEUTIC RADIOPHARMACEUTICALS
                V10XX Various therapeutic radiopharmaceuticals
                 V10XX03 Radium (223Ra) dichloride
                  D10398  Radium Ra 223 dichloride (USAN) &lt;JP/US&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D10398  Radium Ra 223 dichloride (USAN)
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10398
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10398
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10398
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10398
DBLINKS     CAS: 444811-40-9
            PubChem: 172232491
            ChEBI: 74895
ATOM        3
            1   Z   Ra   13.7900  -12.6700
            2   X   Cl   15.2824  -13.6500
            3   X   Cl   12.2976  -13.6500
BOND        2
            1     1   2 1
            2     1   3 1
///
